A detailed history of Goodman Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Goodman Advisory Group, LLC holds 460 shares of LLY stock, worth $362,567. This represents 0.12% of its overall portfolio holdings.

Number of Shares
460
Previous 460 -0.0%
Holding current value
$362,567
Previous $416,000 2.16%
% of portfolio
0.12%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$724.87 - $909.04 $255,154 - $319,982
-352 Reduced 43.35%
460 $416,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $208,454 - $278,882
352 Added 76.52%
812 $631,000
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $128,215 - $150,544
460 New
460 $149,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Goodman Advisory Group, LLC Portfolio

Follow Goodman Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goodman Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goodman Advisory Group, LLC with notifications on news.